Economic evaluation of non-invasive tests of fibrosis and cirrhosis
The economic evaluation of non-invasive tests of fibrosis and cirrhosis is being jointly conducted between researchers at HERG and at the Royal Free Hospital. It will assess the cost-effectiveness of the non-invasive assessment and monitoring of liver fibrosis and cirrhosis in patients with suspected or established chronic liver disease. The evaluation will be based on secondary data analysis and economic modelling. It builds on previous collaborative research conducted at HERG in the clinical area of liver disease.